The University of Chicago Header Logo

High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study.

High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study. Am J Hematol. 1986 Oct; 23(2):131-4.

View in: PubMed